After taking a day for reflection on her sons' lives with DMD, columnist Betty Vertin says she feels more on top of their care.

CureDuchenne is investing $1 million in Entos Pharmaceuticals to support the development of a new DMD gene therapy.

DMD treatment SAT-3247 was safe and well-tolerated, and showed signs of increasing muscle strength in five adults, Satellos ...

A couple of speeches recently helped columnist Betty Vertin newly appreciate how much motherhood has been her life purpose.

Long-term data from Genethon’s GNT0004 Phase 1/2 trial reveal sustained motor function in boys with Duchenne muscular ...

New data demonstrated the benefits of Elevidys, a gene therapy for multiple Duchenne muscular dystrophy, in different age ...

A number of strategies can help to ensure adequate joint care to best manage joint pain and stiffness in Duchenne muscular ...

Columnist Shalom Lim stood up for his right to inclusive access to a major sporting event — and a local soccer club responded ...